UK lagging behind with bowel cancer drug test
More than 60% of patients with advanced bowel cancer have not been tested to find out if they could benefit from a drug which might extend their life, research claims.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units